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1684-1182/Copyright ª 2015, TaiwanAbstract Background/Purpose: Along with the improving vaccine coverage, suspected
vaccine-associated measles has been reported in Zhejiang Province, China. In order to main-
tain the accuracy of the measles surveillance system, it is critical to discriminate between
measles vaccine and wild-type virus.
Methods: Eight suspected cases of vaccine-associated measles were reported in Zhejiang Prov-
ince during 2011 and 2014. Sera collected within 4 days and throat swabs collected within
6 days after rash onset were tested with immunoglobulin M and measles virus (MeV) RNA to
confirm MeV infection. In order to further identify the vaccine-associated cases, throat swabs
with positive MeV RNA were tested using an allelic discrimination real-time reverse transcrip-
tase polymerase chain reaction (rRT-PCR) assay developed in this study, RT-PCR-restriction
fragment length polymorphism (RFLP) recommended by the National Measles Laboratory,
and RT-PCR followed by sequencing and genotyping.
Results: Combining anti-measles immunoglobulin M and RNA testing, eight cases were
confirmed as MeV infection. Of the eight, two were identified as vaccine-associated cases
by the allelic discrimination rRT-PCR assay, and one was identified by RT-PCR-RFLP. Subse-
quent sequencing and genotyping confirmed that the sequences of the two cases were iden-
tical to that of the Chinese vaccine strain. The developed allelic discrimination rRT-PCR was
10 times more sensitive than the RT-PCR-RFLP assay when RNA standards generated from three
genotypes of MeV were tested.ory of Emergency Detection for Public Health of Zhejiang Province, Zhejiang Provincial Center for
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of Microbiology, Immunology and InfConclusion: Vaccine-associated measles has been identified in Zhejiang. The developed allelic
discrimination rRT-PCR assay is rapid and sensitive, which will facilitate the surveillance for
vaccine-associated measles.
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Measles is a highly contagious disease, which resulted in
millions of deaths in the pre-vaccine era. The morbidity and
mortality of measles have declined considerably since the
1960s, when the attenuated or killed measles vaccine was
developed and used successfully throughout the world.1,2
After decades of improved immunization coverage and
decreasing incidence, the elimination of measles became
the goal of the World Health Organization (WHO) in its four
regions by 2015.3 To achieve this goal in China, WHO has
recommended a measles mass immunization campaign
(MMIC) in addition to two doses of routine vaccination.
Measles-containing vaccines, the most effective means
to control and interrupt measles infection at present,4 have
been used globally for w50 years. Although the vaccines
have been proved to be safe and effective, previous studies
have found that the live attenuated vaccine may cause
measles-like symptoms, such as moderate fever, rash, and
conjunctivitis, in 5e15% of recipients.5,6 With the apparent
drop in the incidence of wild-type measles, the epidemi-
ology and clinical pattern of the disease have changed, and
vaccine-associated measles has been reported in many
countries.7e10 In order to ensure the accuracy of the mea-
sles surveillance system during the period of measles
elimination, vaccine-associated measles should be distin-
guished from wild-type measles virus (MeV) infection when
cases are reported.
Differentiation of vaccine-associated measles based on
clinical symptoms or laboratory methods routinely used in
MeV surveillance, such as immunoglobulin M (IgM) testing,
virus isolation, and RNA amplification, is unworkable or
unreliable. Sequencing combined with genotyping has al-
ways been the most accessible way to identify vaccine-
associated cases11; however, this method is time
consuming, and not every clinical specimen contains suffi-
cient amount of viral RNA to perform sequencing analysis.12
A reverse transcriptase polymerase chain reaction-
restriction fragment length polymorphism (RT-PCR-RFLP)
assay has been developed and recommended for discrimi-
nating between measles vaccine and wild-type strains by
the Chinese National Measles Laboratory.13 The process of
the RT-PCR-RFLP is divided into RT-PCR plus enzyme
digestion and gel electrophoresis, which are not only labor
intensive but can easily cause crossover contamination as
well. A loop-mediated isothermal amplification assay has
also been developed for differentiating vaccine from wild-
type MeVs in Japan.12 This assay is simpler than RT-PCR-
RFLP, but its sensitivity for detecting wild-type MeV
strains is w10 times lower than it is for detecting vaccine-
type strains.12C-P, et al., Laboratory diagnosis o
ection (2015), http://dx.doi.org/In this paper, we describe the differentiation process of
eight suspected vaccine-associated measles monitored in
Zhejiang Province, China. We have developed an allelic
discrimination real-time RT-PCR (rRT-PCR) assay and
applied it to discriminate between measles vaccine and
wild-type strains. Our research provides data for the labo-
ratory diagnosis of vaccine-associated measles case and
contributes to the accuracy of the measles case surveil-
lance system.
Methods
Suspected vaccine-associated measles
Eight suspected vaccine-associated measles were reported
in Zhejiang Province, China during 2011 and 2014. All the
suspected cases were vaccinated with live attenuated
measles and rubella combined vaccine 4e11 days prior to
the onset of rash. Patients presented with symptoms of
fever and rash, which are consistent with measles clinically
(Table 1). Cases 1 and 7 were reported to present with
typical Koplik’s spots. Cases 2e4 and 6 presented with
symptoms of cough, conjunctivitis, and coryza (3C). Case 1
was also reported to have enlarged lymph nodes. Cases 1,
2, and 6 had been hospitalized prior to onset of illness
(Table 1).
Specimens
Clinical specimens of eight suspected vaccine-associated
cases were used in this study. Serum samples collected
within 4 days after rash onset were tested by enzyme-
linked immunosorbent assay kit (Virion\Serion, Wu¨rzburg,
Germany). Throat swab specimens collected within 6 days
after rash onset were analyzed by a multiplex rRT-PCR for
MeV and rubella virus (RV) routinely used in Zhejiang Pro-
vincial Center for Disease Control and Prevention (CDC),14
as well as used for virus isolation.15 Afterwards, throat
swabs with positive MeV RNA were tested using the allelic
discrimination rRT-PCR developed in this study, RT-PCR-
RFLP recommended by the National Measles Laboratory,13
and RT-PCR followed by sequencing and genotyping.16
RNA extraction
Total RNA was extracted from clinical specimens or cell
culture supernatants using the High Pure Viral Nucleic Acid
Kit (Roche, Welwyn Garden City, UK). Briefly, 200 mL of
clinical specimen or cell culture supernatant was added to
a lysis buffer containing poly (A) and proteinase K andf vaccine-associated measles in Zhejiang Province, China, Journal
10.1016/j.jmii.2015.10.004
Table 1 Clinical information for eight suspected vaccine-associated measles
Case
No.
Date of
birth
Date of
vaccination
Date of
fever
Date of
rash onset
Clinical symptoms Ever been
hospitalizedKoplik’s
spots
Cough Coryza Conjunctivitis Enlargement of
lymph nodes
1 28 Jul 2010 18 Apr 2011 27 Apr 2011 28 Apr 2011 O O Yes
2 1 Jan 2012 15 Mar 2013 22 Mar 2013 25 Mar 2013 O O O Yes
3 24 Jul 2012 26 Mar 2013 2 Apr 2013 4 Apr 2013 O No
4 9 Dec 1986 4 Apr 2013 8 Apr 2013 10 Apr 2013 O No
5 3 Sep 2012 3 May 2013 11 May 2013 12 May 2013 No
6 10 Jul 2012 18 Mar 2013 19 Mar 2013 22 Mar 2013 O O O Yes
7 18 Jun 2013 20 Feb 2014 28 Feb 2014 2 Mar 2014 O No
8 13 Jun 2013 13 Feb 2014 22 Feb 2014 24 Feb 2014 No
Differentiation of vaccine-associated measles 3
+ MODELincubated at 72C for 10 minutes. The sample was run
through the High Pure Spin Filter column and the RNA was
bound to the glass fiber fleece. The contaminants, including
salts, protein, and cellular contaminants, were removed
through several wash and spin steps. The purified RNA was
eluted into 50 mL Elution Buffer and then stored at 80C.
Allelic discrimination rRT-PCR assay
Whole-genome sequences of 16 MeVs, including seven
vaccine strains (genotype A) and nine wild-type strains
(genotypes H1a, H1b, B3, D3, D5, D6, D7, D8, and G3), were
downloaded from GenBank. Multiple sequence alignments
were performed using BioEdit software (Figure 1). The
allelic discrimination site was searched through the whole
genome. Primer pair and TaqMan-minor groove binder
(MGB) probes containing the allelic discrimination site were
designed using PrimerExpress 3.0 software (Applied Bio-
systems, Foster City, CA, USA). Sequences and positions of
the primer pair and TaqMan-MGB probes are shown in Table
2. The probe for detecting wild-type MeV (wild-type probe:
50-FAM-CTTCCAGCAGGCG-NFQ-MGB) was labeled with FAMFigure 1. Primer pair and probes designed for the allelic discrim
action assay. The upper part shows sequence alignments between s
shows sequences of the primer pair, vaccine probe and wild-type p
different between vaccine and wild-type strains. The vaccine prob
fluorescein) fluorescence, respectively, at the 50 end.
Please cite this article in press as: Xu C-P, et al., Laboratory diagnosis o
of Microbiology, Immunology and Infection (2015), http://dx.doi.org/(6-carboxy-fluorescein) at the 50 end, while the probe for
detecting measles-vaccine strain (Vaccine probe: 50-VIC-
CATGCTTCCAACAGG-NFQ-MGB) was labeled with VIC fluo-
rescence. MGB was labeled at the 30 end of the two probes.
The allelic discrimination rRT-PCR was performed using
One Step PrimeScript RT-PCR (Perfect Real-time) kit
(TaKaRa Biotechnology Co., Kusatsu, Japan). Each 25-mL
reaction mixture contained 12.5 mL 2 One Step RT-PCR
Buffer, 0.5 mL TaKaRa Ex Hot start (HS) Taq, 0.5 mL Prime-
Script RT Enzyme Mix, 0.5 mL each primer, 0.25 mL each
probe, 5 mL deionized distilled water, and 5 mL RNA tem-
plate. The final concentration of each primer and probe
was 0.4mM and 0.2mM, respectively. The optimal amplifi-
cation conditions are shown in Table 2. FAM and VIC fluo-
rescence signals were acquired at the end of each
annealing step.
Preparation of MeV RNA standards
Three MeV strains were used to prepare RNA standards.
Measles vaccine was produced by Shanghai Institute of
Biological Products, Shanghai, China, of which genotype Aination real-time reverse transcriptase polymerase chain re-
even vaccine strains and nine wild-type strains. The lower part
robe. The highlighted location indicates the nucleotide that is
e and wild-type probe is labeled with VIC and FAM (6-carboxy-
f vaccine-associated measles in Zhejiang Province, China, Journal
10.1016/j.jmii.2015.10.004
Table 2 Details of the allelic discrimination rRT-PCR assay
Items Allelic discrimination rRT-PCR
Primer pair (20 pmol/mL) Forward 50-CGACAACACGRACAGATGAYAA-30 (nt 8373e8394)
Reverse 50-CAGAGTGCTTGGATTTTRCCCTTRC-30 (nt 8451e8427)
Probes (20 pmol/mL) Wild type 50-FAM- CTTCCAGCAGGCG-NFQ-MGB-30 (nt 8413e8425)
Vaccine 50-VIC-CATGCTTCCAACAGG-NFQ-MGB-30 (nt 8409e8423)
Program 42C 15 min
95C 2 min
94C 10 sec
40 cycles60C 35 sec
Data collection
Sensitivity
RNA standard of genotype A virus 10 copies/mL
RNA standard of genotype H1 virus 10 copies/mL
RNA standard of genotype D4 virus 10 copies/mL
Time for process w1.5 h
Application Discrimination between vaccine & wild-type measles virus
rRT-PCR Z real-time polymerase chain reaction.
4 C.-P. Xu et al.
+ MODELstrain Shanghai-191 (GenBank accession No. FJ416067) was
incorporated. Genotype H1 strain MVi/Zhejiang.CHN/
12.09/1 was isolated from an acute measles case in Zhe-
jiang CDC. Genotype D4 strain was donated by the National
Measles Laboratory.
Three genotypes of RNA standard were generated as
previous described.17 H gene fragment [nucleotides (nt)
7178e9224] was amplified using RNA template of three
MeV strains with primers containing T7 promoter sequence
and were in vitro transcribed with T7 RNA polymerase
(TaKaRa Biotechnology Co.). The sequence of the forward
primer was 50-ACTCGTTAATACGACTCACTATAGGGAG
CCAGCATCAATCCCACCTGAA-30 (T7 promoter sequence
were highlighted in bold) (nt 7178e7198) and the reverse
primer was 50-CCACTTGGACCCTACGTT-30 (nt 9224e9207).
The synthetic RNA transcripts were purified, qualified and
then 10-fold diluted, ranging from 106 copies/mL to
100 copies/mL.
Specificity and sensitivity of the allelic
discrimination rRT-PCR
Specificity of the allelic discrimination rRT-PCR assay was
determined using RNA extracted from cell culture super-
natant of three genotypes of MeV, RV, mumps virus, and
influenza virus subtype A, as well as the clinical specimens
from patients infected with enterovirus 71 and coxsack-
ievirus A16. Sensitivity was assessed through performing the
allelic discrimination rRT-PCR in parallel with the RT-PCR-
RFLP on serial diluted (106e100 copies/mL) RNA standards
generated from three genotypes of MeV. Throat swabs from
eight suspected vaccine-associated cases were also used to
validate the developed assay.
RT-PCR-RFLP
We used the RT-PCR-RFLP assay recommended for
discriminating between MeV vaccine and wild-type strains
in China.13 A fragment located within nt 7516e7953 on thePlease cite this article in press as: Xu C-P, et al., Laboratory diagnosis o
of Microbiology, Immunology and Infection (2015), http://dx.doi.org/MeV H gene was amplified by RT-PCR. The 438 nt RT-PCR
product contained a restriction enzyme cutting site at nt
7666e7671. Measles vaccine strain (genotype A) can be cut
into two fragments (287 nt and 151 nt length bands) after
enzyme digestion; however, none of the wild-type strains
can be cut by enzyme, and only one band can be observed
in gel electrophoresis.
RT-PCR followed by sequencing and genotyping
The 450 nt sequence at the C terminus of the N gene was
amplified by RT-PCR using PrimeScript One Step RT-PCR Kit
(TaKaRa Biotechnology Co.) and primer pair MeV214 and
MeV216 that were routinely used to perform genotyping of
MeV.16 Five microliters of RNA was used as a template for
RT-PCR. The first round of nested RT-PCR was generated by
primer pair MeV214 and MeV216.16 The primer pair for the
second round was originated from MeV214 and MeV216 with
slight modifications. The sequence of the forward primer
was 50-GGAGCTATGCCATGGGAGTAG-30 (nt 1105e1125) and
the reverse primer was 50-AACAATGATGGAGGGTAGGCG-30
(nt 1736e1716). RT-PCR products were purified using the
MinElute PCR Purification Kit (Qiagen, Hilden, Germany)
and sequenced by Sangon Biotech (Shanghai, China). The
phylogenetic tree was drawn based on the 450 nt sequences
of 23 reference strains,18 and six sequences generated in
this study (Table 3), as well as Chinese vaccine strain
Shanghai-191 (GenBank accession No. FJ416067), using the
neighboring-joining and the Kimura two-parameter model
of MEGA version 5.0 software (http://www.megasoftware.
net).19
Results
Confirmation of MeV infection
For case confirmation, anti-measles IgM testing, MeV and RV
RNA amplification, and virus isolation were performed. Of
the eight cases, six were positive for anti-measles IgM, butf vaccine-associated measles in Zhejiang Province, China, Journal
10.1016/j.jmii.2015.10.004
Table 3 Laboratory test results for eight suspected cases of vaccine-associated measles
Case
No.
Date sample
collection
IgM Multiplex
rRT-PCR
Virus
isolation
Developed
rRT-PCR
RT-PCR-RFLP RT-PCR Sequence name
(genotype)
Sera Throat swab Results Channel Results No. band
1 29 Apr 2011 30 Apr 2011 Pos Pos/MeVa Neg Pos VIC Pos Two Pos MVs/Zhejiang.CHN/
17.11 (A)
2 25 Mar 2013 28 Mar 2013 Pos Pos/MeV Pos Pos FAM Pos One Pos MVi/Zhejiang.CHN/
13.13/12 (H1)
3 4 Apr 2013 4 Apr 2013 Pos Pos/MeV Pos Pos FAM Pos One Pos MVi/Zhejiang.CHN/
14.13/14 (H1)
4 11 Apr 2013 11 Apr 2013 Neg Pos/MeV Pos Pos FAM Pos One Pos MVi/Zhejiang.CHN/
15.13/1 (H1)
5 14 May 2013 15 May 2013 Pos Pos/MeV Neg Pos FAM Neg Neg
6 25 Mar 2013 28 Mar 2013 Pos Pos/MeV Pos Pos FAM Pos One Pos MVi/Zhejiang.CHN/
12.13/8 (H1)
7 6 Mar 2014 6 Mar 2014 Pos Pos/MeV Neg Pos FAM Neg Neg
8 26 Feb 2014 25 Feb 2014 Neg Pos/MeV Neg Pos VIC Neg Neg Posb MVs/Zhejiang.CHN/
12.14 (A)
a Pos/MeV means positive for MeV RNA.
b Sequence for genotyping was obtained by nested RT-PCR.
FAM Z 6-carboxy-fluorescein; IgM Z immunoglobulin M; MeV Z measles virus; Neg Z negative; POS Z positive; rRT-PCR Z real-time
polymerase chain reaction; VIC Z .
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+ MODELCases 4 and 8 whose serum specimens were collected
within 2 days after rash onset gave negative results (Table
3). All eight cases were positive for MeV RNA but negative
for RV RNA (Table 3). Combining the results of anti-measles
IgM and MeV RNA, the eight cases were all confirmed as MeV
infection. In addition, four MeV strains were isolated from
Cases 2e4 and 6 (Table 3).
Evaluation of the allelic discrimination rRT-PCR
assay
An allelic discrimination rRT-PCR assay was developed for
differentiating between MeV vaccine and wild-type strains.
Based on the result of multiple sequence alignments on the
MeV genome (Figure 1), site nt 8419 located within the H
gene was selected as an allelic discrimination site. MeV
vaccine strains contain nucleotide A, while wild-type
strains contain nucleotide G (Figure 1) on the site. Two
TaqMan-MGB probes used in the assay were designed to
hold the allelic discrimination site (nt 8419) and were
labeled with different fluorescence (VIC and FAM). MeV
vaccine and wild-type strains can be differentiated based
on fluorescence signals acquired after amplification.
Specificity evaluation of the allelic discrimination rRT-
PCR showed that the assay has no cross-reactivity against
other respiratory viruses, except for three genotypes of
MeV. Moreover, positive result on the VIC channel was only
generated by genotype A MeV, while positive results on the
FAM channel were detected from genotype H1 and D4 MeVs.
Sensitivity of the allelic discrimination rRT-PCR was
assessed and compared with the RT-PCR-RFLP assay. When
RNA standards were tested, detection limits of the allelic
discrimination rRT-PCR assay were 10 copies/mL for three
genotypes of MeV (Figure 2 and Table 2), while the lowest
concentration RT-PCR-RFLP assay could detect wasPlease cite this article in press as: Xu C-P, et al., Laboratory diagnosis o
of Microbiology, Immunology and Infection (2015), http://dx.doi.org/100 copies/mL. Through enzyme digestion, two specific
bands with 287 nt and 151 nt in length were observed in the
gel picture of genotype A RNA standard (Figure 2B), but
only one band of 438 nt in length was observed in the pic-
ture of genotype H1 or D4 RNA standards, respectively
(Figure 2D and F). In addition, the allelic discrimination
rRT-PCR was faster than RT-PCR-RFLP, as the whole process
only needed w1.5 hours.Identification and confirmation of vaccine-
associated cases
In order to discriminate whether or not the eight cases were
caused by measles vaccine, throat swabs were tested using
the allelic discrimination rRT-PCR in parallel with RT-PCR-
RFLP assay. All the cases tested positive for MeV RNA using
allelic discrimination rRT-PCR, two of which (Cases 1 and 8)
acquired positive results from channel VIC and were iden-
tified as vaccine-associated measles, while the other six
were tested as positive in channel FAM and identified as
wild-type MeV infection (Table 3). Five (Cases 1e4 and 6) of
the eight cases were detected as positive by the RT-PCR-
RFLP assay, among which only Case 1 was identified as a
vaccine-associated case, as there were two bands observed
in the electrophoretogram (Table 3).
RT-PCR followed by sequencing and genotyping was used
to confirm the results of allelic discrimination rRT-PCR. Six
of the eight tested positive by RT-PCR, of which, two (MVs/
Zhejiang.CHN/17.11 and MVs/Zhejiang.CHN/12.14) were
directly generated from clinical specimens of Cases 1 and 8,
and another four were generated from cell culture super-
natants. The sequence of Case 8 was generated by nested
RT-PCR, since there was a weak band after routine RT-PCR
amplification.f vaccine-associated measles in Zhejiang Province, China, Journal
10.1016/j.jmii.2015.10.004
Figure 2. Sensitivity evaluation of the allelic discrimination rRT-PCR using RNA standards generated from three genotypes of
measles virus. A and B indicate the detection limits of the allelic discrimination rRT-PCR and RT-PCR-RFLP for genotype A RNA
standard. C and D show the detection limits of the two assays for genotype H1 RNA standard. E and F show the sensitivity for
genotype D4 RNA standard. The genotype of each RNA standard was labeled on the top left of A, C and E. The size of the DNA
marker was labeled on the left of the electrophoretogram. The dilutions of the RNA standard ranged from 106 copies/mL to 100
copies/mL. M Z DNA marker; RFLP Z restriction fragment length polymorphism; rRT-PCR Z real-time reverse transcriptase po-
lymerase chain reaction.
6 C.-P. Xu et al.
+ MODELThe phylogenetic tree (Figure 3) showed that MVs/Zhe-
jiang.CHN/17.11 and MVs/Zhejiang.CHN/12.14 were
located in the same branch with Edmonston-wt. USA/54,
the reference strain of genotype A MeV, and were identical
to the Chinese vaccine strain Shanghai-191 (GenBank
accession No. FJ416067). Hence, these two were confirmed
as vaccine-associated measles. The other four sequences
generated from Cases 2e4 and 6 had the nearest distances
to reference strain Hunan.CHN/93/7, and were identified
as genotype H1 strains. Three of these four sequences
(Cases 3, 4, and, 6) were identical and had seven nucleo-
tides different from the MVi/Zhejiang.CHN/13.13/12
strain, which was generated from Case 2.Discussion
With the acceleration of measles control and elimination in
recent years, atypical and vaccine-associated measles have
been monitored worldwide.7e10 Many cases suspected toPlease cite this article in press as: Xu C-P, et al., Laboratory diagnosis o
of Microbiology, Immunology and Infection (2015), http://dx.doi.org/correlate with vaccine administration have been reported
in Zhejiang Province, China, since a nationwide MMIC car-
ried out in 2010 when >2 million children aged from
8 months to 4 years were immunized in Zhejiang Province
with measles-containing vaccine.20
In this study, we focused on eight suspected cases of
vaccine-associated measles that occurred in Shaoxing City
of Zhejiang Province during 2011 and 2014. On arrival at the
hospital, all of the patients presented with symptoms of
fever and red maculopapules. They were clinically diag-
nosed as measles and reported to the local CDC. It was
subsequently discovered that they had been immunized
with measles and rubella combined vaccine 4e11 days prior
to rash onset. Based on the first definition of vaccine-
associated measles by the WHO,21e23 hospital staff doubted
whether the cases were caused by the measles vaccine. In
order to determine if there was a connection, serum and
throat swab specimens were collected and used to perform
laboratory diagnosis.f vaccine-associated measles in Zhejiang Province, China, Journal
10.1016/j.jmii.2015.10.004
Figure 3. Phylogeny analysis of the suspected vaccine-
associated cases. This phylogenetic tree was constructed
based on the 450 nucleotide sequence of N gene generated
from six suspected vaccine-associated measles and the refer-
ence strain for each genotype using the neighboring-joining
and Kimura two-parameter model of the MEGA version 5.0
software. The reliability of the constructed tree was estimated
by bootstrap analysis with 1000 replicates. Bootstrap
values > 70 were labeled above the nodes. The sequences of 23
reference strains were downloaded from GenBank. The geno-
type of the reference strain was marked within square brackets
at the end of the name. The two sequences identified as ge-
notype A by allelic discrimination real-time reverse transcrip-
tase polymerase chain reaction were highlighted in red and the
four genotype H1 sequences were highlighted in blue.
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IgM, and six cases were in accordance with the second
definition of vaccine-associated measles, that is, blood
samples collected 8e56 days after vaccination should be
positive for anti-measles IgM.21e23 However, we could not
exclude the two IgM-negative cases (Cases 4 and 8), since
up to 30% of tests for measles-specific IgM may give false-
negative results in the first 3 days after rash onset.21,24
Indeed, the two cases with negative IgM were subse-
quently confirmed as measles as well through MeV RNA
amplification.
It is difficult to distinguish vaccine-associated measles
from the wild-type infection using routine methods.
Therefore, we developed an allelic discrimination rRT-PCR
assay in this study, in order to improve the accuracy of
differential diagnosis for these eight cases. Using vaccine-
specific and wild-type-specific probes containing the allelic
discrimination site (nt 8419), the measles vaccine strain
could be easily distinguished from 22 genotypes of wild-Please cite this article in press as: Xu C-P, et al., Laboratory diagnosis o
of Microbiology, Immunology and Infection (2015), http://dx.doi.org/type MeV, based on VIC fluorescent signals. Of the eight
cases, two were identified as vaccine-associated measles
by the new rRT-PCR method. One of these cases (Case 1)
was also identified by the recommended RT-PCR-RFLP
assay. However, Case 8 was tested as negative by RT-PCR-
RFLP, which suggests that the allelic discrimination rRT-PCR
is more sensitive than RT-PCR-RFLP. The results were
confirmed by sensitivity evaluation of the assay (Figure 2).
Our allelic discrimination rRT-PCR method is different from
the loop-mediated isothermal amplification assay used in
Japan,12 because the detection limits (10 copies/mL) of the
allelic discrimination rRT-PCR are similar between vaccine
and wild-type MeVs, which could help eliminate false-
negative results when detecting wild-type MeV infection.
Subsequent sequencing and genotyping analysis confirmed
that Cases 1 and 8 were caused by the measles vaccine, as
sequences generated from the two cases were identical to
the Chinese vaccine strain Shanghai-191 (Figure 3).
After confirming the results, we summarized the clinical
features of the eight cases by retrospective analysis. Pre-
vious studies found that the incubation period for typical
measles infection is 10 days to the onset of fever and
14 days to the onset of rash,25 but this may be prolonged to
37 days post-immunization for vaccine-associated mea-
sles.10 However, the incubation period of the vaccine-
associated measles cases identified in our study was prob-
ably similar to that of typical measles. The clinical symp-
toms of 3C were included in the definition of wild-type
measles by WHO and were suggested as key positive find-
ings to distinguish wild-type and vaccine MeV infection.22
Cases 1 and 8 in our study had no 3C symptoms, and the
other four cases caused by wild-type MeV presented 3C
symptoms randomly. However, vaccine-associated cases
reported in Canada documented that the patients devel-
oped 3C symptoms, in addition to fever and rash.10 Signif-
icantly, in Case 1, physicians observed Koplik’s spots on the
patient’s oral mucosa, and epidemiologists considered the
patient had the probable route of exposure since the pa-
tient had been to hospital before onset of illness. Hence, it
is unreliable to discriminate between vaccine and wild-type
MeV infection only on the basis of clinical symptoms or
epidemiological history. In addition, Cases 2e4 and 6 were
monitored in Shaoxing City during late March 2013 and early
April 2013. During that period, many measles cases were
reported in the city. Based on our results, it is reasonable to
assume that these patients had already incubated wild-
type MeVs before vaccine inoculation or during the period
from vaccination to onset of illness.
In this study, not every genotype of MeV was real tested
by the developed allelic discrimination rRT-PCR assay since
only three genotypes were available in our laboratory. Even
though the multiple sequence alignment assures the accu-
racy of the assay theoretically, we cannot be completely
certain what the performance of the allelic discrimination
rRT-PCR assay would be in detection of the other 19 ge-
notypes of MeV. Another limitation of the study was that
only a small number of specimens (8 suspected cases) were
detected using the allelic discrimination rRT-PCR, which
may have been insufficient to precisely evaluate the
sensitivity and specificity of the assay. Therefore, the assay
should be further validated with different genotypes of MeV
as well as a large number of clinical samples.f vaccine-associated measles in Zhejiang Province, China, Journal
10.1016/j.jmii.2015.10.004
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+ MODELIn conclusion, the process described in this study for the
identification and confirmation of vaccine-associated
measles cases could improve the accuracy of the measles
case surveillance system. Moreover, the allelic discrimina-
tion rRT-PCR assay provides a good alternative for differ-
entiating between vaccine and wild-type MeV.
Conflicts of interest
All contributing authors declare no conflicts of interest.Acknowledgments
This work was financially supported by the fund of Key
Medical Subjects Construction Project of Zhejiang Province
(XKQ-009-003). We gratefully acknowledge the support of
many colleagues in the municipal CDC in Zhejiang.References
1. Enders JF, Peebles TC. Propagation in tissue cultures of cyto-
pathogenic agents from patients with measles. Proc Soc Exp
Biol Med 1954;86:277e86.
2. Baker JP. The first measles vaccine. Pediatrics 2011;128:
435e7.
3. Perry RT, Gacic-Dobo M, Dabbagh A, Mulders MN, Strebel PM,
Okwo-Bele JM, et al. Progress toward regional measles elimi-
nation e worldwide, 2000e2013. MMWR Morb Mortal Wkly Rep
2014;63:1034e8.
4. World Health Organization. Measles vaccines. Wkly Epidemiol
Rec 2009;84:349e60.
5. Makino S. Development and characteristics of live AIK-C mea-
sles virus vaccine: a brief report. Rev Infect Dis 1983;5:504e5.
6. Strebel P, Papania M, Halsey N. Measles vaccine. In: Vaccine.
Atlanta: Elsevier; 2004. p. 389e440.
7. Nestibo L, Lee BE, Fonseca K, Beirnes J, Johnson MM,
Sikora CA. Differentiating the wild from the attenuated during
a measles outbreak. Paediatr Child Health 2012;17:e32e3.
8. Aoki Y, Mizuta K, Ikeda T, Abiko C, Itagaki T, Ahiko T. Isolation
of vaccine-derived measles viruses from children with acute
respiratory infection. Tohoku J Exp Med 2013;230:111e5.
9. Hau M, Schwartz KL, Frenette C, Mogck I, Gubbay JB,
Severini A, et al. Local public health response to vaccine-
associated measles: case report. BMC Public Health 2013;13:
269.
10. Murti M, Krajden M, Petric M, Hiebert J, Hemming F, Hefford B,
et al. Case of vaccine-associated measles five weeks post-
immunisation, British Columbia, Canada, October 2013. EuroPlease cite this article in press as: Xu C-P, et al., Laboratory diagnosis o
of Microbiology, Immunology and Infection (2015), http://dx.doi.org/Surveill 2013;18. http://dx.doi.org/10.2807/1560-7917.
ES2013.18.49.20649.
11. Berggren KL, Tharp M, Boyer KM. Vaccine-associated “wild-
type” measles. Pediatr Dermatol 2005;22:130e2.
12. Nakayama T, Sawada A, Kubo H, Kaida A, Tanaka T,
Shigemoto N, et al. Simple method for differentiating measles
vaccine from wild-type strains using loop-mediated isothermal
amplification. Microbiol Immunol 2013;57:246e51.
13. Zhou JH, Wang S, Chen C. The establishment of method for
identifying China vaccine strains and wild strains of measles
virus. Zhongguo Yi Miao He Mian Yi 2009;15:310e5.
14. Yu BB, Feng Y, Xu CP, Lu YY, Qian J. Simultaneous detection of
measles and rubella virus by multiplex real-time RT-PCR with
an internal control. Bing Du Xue Bao 2010;26:109e14.
15. Keniscope C, Juliana R, Subri H, Shangari SR, Wan Nor
Azlina WA, Hamizah A, et al. Isolation of measles virus from
clinical specimens using B95a and Vero/hSLAM cell-lines. Med J
Malaysia 2009;64:37e40.
16. Bankamp B, Byrd-Leotis LA, Lopareva EN, Woo GK, Liu C, Jee Y,
et al. Improving molecular tools for global surveillance of
measles virus. J Clin Virol 2013;58:176e82.
17. Sun Y, Liang M, Qu J, Jin C, Zhang Q, Li J, et al. Early diagnosis
of novel SFTS bunyavirus infection by quantitative real-time
RT-PCR assay. J Clin Virol 2012;53:48e53.
18. World Health Orgainization. Update of the nomenclature for
describing the genetic characteristics of wild-type measles
viruses: new genotypes and reference strains. Wkly Epidemiol
Rec 2003;78:229e32.
19. Tamura KPD, Peterson N, Stecher G, Nei M, Kumar S. MEGA5:
molecular evolutionary genetics analysis using maximum like-
lihood, evolutionary distance, and maximum parsimony
methods. Mol Biol Evol 2011;28:2731e9.
20. Gao J, Chen E, Wang Z, Shen J, He H, Ma H, et al. Epidemic of
measles following the nationwide mass immunization
campaign. BMC Infect Dis 2013;13:139.
21. World Health Organization. Manual for the laboratory diagnosis
of measles and rubella infection. Geneva: WHO 2007: Available
at:http://www.who.int/ihr/elibrary/manual_diagn_lab_mea_
rub_en.pdf. [accessed 26.12.14].
22. Choe YJ, Eom HS, Bae GR. Vaccine-associated measles in the
low-incidence country of Korea over a 10-year period. Jpn J
Infect Dis 2014;67:180e3.
23. World Health Organization Regional Office for the Western
Pacific. 23rd session of Regional Committee. Hanoi, Viet Nam,
2012: Available at:http://www.wpro.who.int/about/regional_
committee/63/documents/RC_07_Item_12_Measles_
elimination_FINAL_COMPLETE.pdf. [accessed 26.12.14].
24. Helfand RF, Heath JL, Anderson LJ, Maes EF, Guris D,Bellini WJ.
Diagnosis of measles with an IgM capture EIA: the optimal
timing of specimen collection after rash onset. J Infect Dis
1997;175:195e9.
25. Moss WJ, Griffin DE. Measles. Lancet 2012;379:153e64.f vaccine-associated measles in Zhejiang Province, China, Journal
10.1016/j.jmii.2015.10.004
